Switch to:
More From Other Websites
Who Really Won in the PDL and Ariad Royalty Deal? Jul 29 2015
ARIAD to Receive up to $200 Million Through Iclusig Non-Dilutive Synthetic-Royalty Financing with... Jul 29 2015
PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals Jul 29 2015
PDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of... Jul 29 2015
PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals Jul 29 2015
PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 Jul 28 2015
PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 Jul 28 2015
Buy PDL BioPharma For Strong Upside and High Dividend Yield Jul 21 2015
PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jun 30 2015
PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications Jun 29 2015
PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications Jun 29 2015
PDL BIOPHARMA, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation... Jun 29 2015
PDL BioPharma to Present at the Nasdaq 32nd Investor Program Jun 25 2015
PDL BioPharma to Present at the Nasdaq 32nd Investor Program Jun 25 2015
PDL BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events,... Jun 24 2015
PDL BioPharma Appoints Steffen Pietzke as Controller and Chief Accounting Officer Jun 24 2015
PDL BioPharma Appoints Steffen Pietzke as Controller and Chief Accounting Officer Jun 24 2015
5 Biotech Stocks to Trade for Gains Jun 23 2015
PDL BioPharma Completes Regular Quarterly Dividend Payment Jun 15 2015
PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 15 2015
PDL BioPharma Completes Regular Quarterly Dividend Payment Jun 15 2015
PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jun 02 2015
PDL BIOPHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 29 2015
PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits May 28 2015
PDL BioPharma to Present at Jefferies 2015 Global Healthcare Conference May 27 2015
PDL BioPharma to Present at Jefferies 2015 Global Healthcare Conference May 27 2015
Lightning Round: This is a one way ticket down May 21 2015
Weekly 3-Year Low Highlights: APOL, PDLI, TC, ALLT, ELRC May 17 2015
PDL BIOPHARMA, INC. Financials May 13 2015
DEPO: Selloff Creates Great Opportunity In Depomed May 13 2015
PDL BioPharma posts 1Q profit May 06 2015
PDL BioPharma Announces First Quarter 2015 Financial Results May 06 2015
PDL BioPharma Completes Regular Quarterly Dividend Payment Mar 12 2015
PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note Mar 04 2015
PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit Mar 03 2015
PDL BioPharma Announces Fourth Quarter and Full Year 2014 Financial Results Mar 03 2015
PDL BioPharma to Hold Annual Meeting of Stockholders on May 28, 2015 Mar 03 2015
PDL BioPharma to Announce Fourth Quarter and Full Year 2014 Financial Results on February 23, 2015 Feb 17 2015
PDL BioPharma Announces 2015 Regular Quarterly Dividends Jan 29 2015
PDL BioPharma Completes Regular Quarterly Dividend Payment Dec 15 2014
PDL BioPharma Provides Fourth Quarter 2014 Revenue Guidance of $158 Million Dec 10 2014
PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes Dec 04 2014
PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics Dec 01 2014
PDL BioPharma posts 3Q profit Nov 10 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK